Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. (“Auxilium” or “the Company”) (NasdaqGS: AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to QLT Inc.(NasdaqGS: QLTI).

Click here to learn more about the investigation: http://zlk.9nl.com/auxilium-pharmaceuticals-auxl, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Auxilium shareholders will receive 3.1359 shares of QLT Inc. for each share of Auxilium they own. The investigation concerns whether the Board of Auxilium breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether QLT Inc. is underpaying for Auxilium shares.

If you own Auxilium common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/auxilium-pharmaceuticals-auxl.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.